We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
-21.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.3M
AUM Growth
-$26.6M
Cap. Flow
-$16.7M
Cap. Flow %
-78.3%
Top 10 Hldgs %
66.69%
Holding
94
New
24
Increased
–
Reduced
32
Closed
17

Top Buys

Rank Stock Value
1
TCBPW
TC BioPharm (Holdings) plc Warrants
TCBPW
+$1.31M
2
SBFM
Sunshine Biopharma
SBFM
+$1.12M
3
BRCC.WS
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
+$855K
4
VLNS
The Valens Company, Inc. Common Shares
VLNS
+$854K
5
SLNO
Soleno Therapeutics
SLNO
+$484K

Top Sells

Rank Stock Value
1
ISPC icon
iSpecimen
ISPC
+$3.64M
2
OHAA
OPY Acquisition Corp. I Class A Common Stock
OHAA
+$2.96M
3
AMPE
Ampio Pharmaceuticals Inc.
AMPE
+$2.43M
4
RNERU
Mount Rainier Acquisition Corp. Unit
RNERU
+$2.03M
5
CCTSU
Cactus Acquisition Corp. 1 Limited Unit
CCTSU
+$2.02M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.67%
2 Healthcare 19.72%
3 Technology 3.09%
4 Consumer Staples 1.98%
5 Energy 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRACW
76
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$4K 0.02%
+15,961
New +$5.46K
IMRNW
77
DELISTED
Immuron Limited Warrants
IMRNW
$4K 0.02%
46,161
-1,473
-3% -$394
AEI icon
78
Alset
AEI
$57.2M
– –
-129,724
Closed -$1.45M
CNTX icon
79
Context Therapeutics
CNTX
$38.1M
– –
-358,617
Closed -$954K
ISPC icon
80
iSpecimen
ISPC
$4M
– –
-583
Closed -$3.64M
LGVN
81
Longeveron
LGVN
$22.2M
– –
-544
Closed -$656K
RGLS
82
DELISTED
Regulus Therapeutics
RGLS
– –
-507,425
Closed -$1.6M
SCYX icon
83
SCYNEXIS
SCYX
$54.9M
– –
-5,412
Closed -$264K
SDOT icon
84
Sadot Group
SDOT
$23.6M
– –
-464
Closed -$669K
SWAG icon
85
Stran & Co
SWAG
$32.1M
– –
-201,208
Closed -$1.22M
CCTSU
86
DELISTED
Cactus Acquisition Corp. 1 Limited Unit
CCTSU
– –
-200,000
Closed -$2.02M
OHAA
87
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
– –
-300,000
Closed -$2.96M
RNERU
88
DELISTED
Mount Rainier Acquisition Corp. Unit
RNERU
– –
-200,000
Closed -$2.03M
VGFC
89
DELISTED
The Very Good Food Company
VGFC
– –
-687,745
Closed -$507K
AMPE
90
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-14,208
Closed -$2.43M
LMPX
91
DELISTED
LMP Automotive Holdings, Inc. Common Stock
LMPX
– –
-33,671
Closed -$235K
GMBTW
92
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
– –
-50,000
Closed -$32K
SBEAW
93
DELISTED
SilverBox Engaged Merger Corp I Warrant
SBEAW
– –
-133,333
Closed -$187K
ENVXW
94
DELISTED
Enovix Corporation Warrant
ENVXW
– –
-17,045
Closed -$268K
1 2 3
4

Similar funds

BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $86.6M AUM
LCM
LDR Capital Management New York $86.7M AUM 16.32% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $86.7M AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
TWM
Tripletail Wealth Management Orlando, Florida $86.9M AUM 39.01% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Empery Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Empery Asset Management held 94 positions worth $21.3M, down 56% from $47.9M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Empery Asset Management withdrew a net $16.7M in Q1 2022, closing 17 positions and reducing 32 holdings. Its most notable exit was iSpecimen, an estimated $3.64M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Empery Asset Management opened a new position in TC BioPharm (Holdings) plc Warrants worth $1.38M.

  • Empery Asset Management's largest Q1 2022 buy was TC BioPharm (Holdings) plc Warrants: 2,823,528 shares worth $1.38M.
  • Empery Asset Management's biggest Q1 2022 reduction was Starling Oncology, cutting an estimated $872K.
  • Empery Asset Management fully exited iSpecimen in Q1 2022, selling an estimated $3.64M.
  • Empery Asset Management's ten largest holdings make up 67% of its $21.3M portfolio in Q1 2022.
  • Empery Asset Management opened 24 new positions and closed 17 in Q1 2022.
  • Empery Asset Management's portfolio value fell 56% quarter-over-quarter to $21.3M.

Based on Empery Asset Management's 13F filing for Q1 2022, filed 16 May 2022.